| anti-(6-4) photoproduct |
2 |
| anti-(T,G)-A--L (poly-(Tyr,Glu)-Ala-Lys) |
5 |
| anti-11-dehydro-thromboxane B2 (11-dehydro TXB2) |
3 |
| anti-17 beta-estradiol |
2 |
| anti-2-phenyl oxazolone |
1 |
| anti-2-phenyl-5-oxazolone (phOx) |
97 |
| anti-4-1BB (CD137) (TNFR superfamily member, T cell activation molecule) [human] |
4 |
| anti-A (blood group A) |
5 |
| anti-A33 (transmembrane glycoprotein) [human] |
8 |
| anti-B (blood group B) |
2 |
| anti-B cell [human fetal spleen] |
9 |
| anti-B cell [lymphoma] |
14 |
| anti-B cell [lymphoma] [human] |
4 |
| anti-BSA |
2 |
| anti-Bluetongue virus VP7 |
2 |
| anti-BrMRBC (bromelain-treated mouse red blood cells) |
12 |
| anti-Brucella |
10 |
| anti-Bt-LC-Z2Ph (Diphenyl N-[6-(biotinamido) hexanoyl] amino (4- amidinophenyl) methanephosphonate) |
2 |
| anti-Burkholderia pseudomallei exotoxin |
2 |
| anti-Burkholderia pseudomallei protease |
2 |
| anti-C3 [guinea pig] |
12 |
| anti-C3 nephritic factor |
2 |
| anti-C3a receptor (C3aR) [human] |
38 |
| anti-C5 |
3 |
| anti-C5 [guinea pig] |
5 |
| anti-C5a |
12 |
| anti-CD10 (cALL) |
1 |
| anti-CD16 [human] |
2 |
| anti-CD18 |
2 |
| anti-CD19 |
4 |
| anti-CD19, anti-CD16 |
1 |
| anti-CD1a |
1 |
| anti-CD20 [human] |
6 |
| anti-CD22 |
1 |
| anti-CD22 [human] |
8 |
| anti-CD23 |
44 |
| anti-CD25 |
1 |
| anti-CD28 |
2 |
| anti-CD28 [human] |
3 |
| anti-CD28/alpha-1 antitrypsine |
1 |
| anti-CD29 |
2 |
| anti-CD3 |
31 |
| anti-CD3 [human] |
5 |
| anti-CD3 [monkey] |
2 |
| anti-CD30 |
4 |
| anti-CD34 |
7 |
| anti-CD34 [human] |
3 |
| anti-CD37 [human] |
2 |
| anti-CD4 |
21 |
| anti-CD4 (Leu3a) [murine] |
3 |
| anti-CD4 [human] |
11 |
| anti-CD40 |
48 |
| anti-CD40 [human] |
24 |
| anti-CD46 |
3 |
| anti-CD5 |
1 |
| anti-CD5 [human] |
1 |
| anti-CD7 [human] |
2 |
| anti-CD72 |
1 |
| anti-CD79B (Ig-beta/B29) [human] |
1 |
| anti-CD8 |
9 |
| anti-CD8 [bovine] |
1 |
| anti-CD95 [human] |
1 |
| anti-CD98 |
2 |
| anti-CHL1 (neural adhesion molecule) [mouse] |
2 |
| anti-Candida albicans surface antigens |
5 |
| anti-CasBrE (murine neurotropic ecotropic retrovirus) envelope glycoprotein VRA motif |
2 |
| anti-Citrus tristeza virus (CTV) coat protein |
1 |
| anti-DNA |
905 |
| anti-DNA double-stranded (ds) |
93 |
| anti-DNA double-stranded (ds), anti-HP8 protein |
1 |
| anti-DNA double-stranded (ds), anti-Sm (ribonucleoprotein RNP) |
3 |
| anti-DNA double-stranded (ds), anti-Sm (ribonucleoprotein RNP), anti-cardiolipin |
1 |
| anti-DNA double-stranded (ds), anti-Sm (ribonucleoprotein RNP), anti-cardiolipin, anti-fibronectin |
3 |
| anti-DNA double-stranded (ds), anti-cardiolipin |
2 |
| anti-DNA double-stranded (ds), anti-fibronectin |
1 |
| anti-DNA double-stranded (ds), anti-glomerule (glomerular-binding, glomerulotropic) |
3 |
| anti-DNA quadruplex |
3 |
| anti-DNA single-stranded (ss) |
126 |
| anti-DNA single-stranded (ss) [bacterial] |
2 |
| anti-DNA single-stranded (ss) [human] |
4 |
| anti-DNA single-stranded (ss), anti-DNA double-stranded (ds) |
2 |
| anti-DNA triplex |
2 |
| anti-DNA, anti-phosphocholine |
1 |
| anti-DNP (2,4-dinitrophenyl) |
42 |
| anti-Dns (anti-5-dimethylaminophtalene-1-sulfonyl) |
10 |
| anti-E-selectin |
4 |
| anti-Ebola virus |
6 |
| anti-Echinococcus granulosus antigen B |
1 |
| anti-Eimeria acervulina apical complex protein |
1 |
| anti-Eimeria acervulina surface antigens |
2 |
| anti-Entamoeba histolytica |
29 |
| anti-EpCAM (epithelial cell adhesion molecule) |
1 |
| anti-EpCAM (epithelial cell adhesion molecule) [human], anti-CD28 |
3 |
| anti-EpCAM (epithelial cell adhesion molecule), anti-CD46 |
1 |
| anti-Epstein-Barr virus (EBV) |
3 |
| anti-Epstein-Barr virus (EBV) nuclear antigen 3, epitope FLRGRAYGL, HLA-B8-restricted |
4 |
| anti-F(ab')2 |
15 |
| anti-F4 alpha (patent) |
3 |
| anti-FB5 |
2 |
| anti-Fas |
283 |
| anti-Fas [human] |
132 |
| anti-Fc epsilon RI (HUGO: FCERI) (receptor for Fc fragment of IgE) |
2 |
| anti-Fc epsilon RI (HUGO: FCERI) (receptor for Fc fragment of IgE, high affinity I) |
10 |
| anti-Fc gamma RI |
5 |
| anti-Fc gamma RIII [human] |
2 |
| anti-Fusarium |
4 |
| anti-GAT (poly(Glu60 Ala30 Tyr10)) |
33 |
| anti-GMP-140 [human] |
6 |
| anti-GRP (glycin-rich cell wall protein) [cereal] |
2 |
| anti-Gal (Gal alpha1-3gal beta1-4glcNAc-R) |
8 |
| anti-Gal (beta-(1,6)-galactan) |
4 |
| anti-Gal (terminal galactose alpha1,3-galactose carbohydrate structures) |
16 |
| anti-HIV-1 (human immunodeficiency virus type 1) |
44 |
| anti-HIV-1 Rev protein |
1 |
| anti-HIV-1 Tat protein |
2 |
| anti-HIV-1 Vif protein |
1 |
| anti-HIV-1 gp120 (envelope protein) |
62 |
| anti-HIV-1 gp120 (envelope protein) (CD4 binding site) |
2 |
| anti-HIV-1 gp120 CD4bs (CD4 binding site) |
20 |
| anti-HIV-1 gp120 V2 |
12 |
| anti-HIV-1 gp120 V3 |
42 |
| anti-HIV-1 gp41 (envelope protein) |
13 |
| anti-HIV-1 p17 (matrix protein) |
5 |
| anti-HIV-1 p24 (capsid protein) |
22 |
| anti-HIV-1 p25 |
4 |
| anti-HIV-1 p31 (integrase) |
2 |
| anti-HIV-1 p34 |
1 |
| anti-HIV-1 reverse transcriptase (RT) |
9 |
| anti-HLA |
12 |
| anti-HLA class II |
22 |
| anti-HLA-A2 |
5 |
| anti-HLA-A2, anti-HLA-A28 |
10 |
| anti-HLA-B7 |
2 |
| anti-HLA-DQ3 |
11 |
| anti-HLA-DR |
4 |
| anti-HM1.24 (patent) |
14 |
| anti-HMWG (high-molecular-weight glycoprotein) [human], anti-CD28 |
2 |
| anti-HMWG (high-molecular-weight glycoprotein) [human], anti-CD95 [human] |
1 |
| anti-HMWG (high-molecular-weight glycoprotein), anti-CD28 |
1 |
| anti-HTLV-1 (human T leukaemia virus type 1) |
1 |
| anti-Haemophilus influenzae type a (Hia) [human] |
2 |
| anti-Haemophilus influenzae type b (Hib) capsular polysaccharide |
5 |
| anti-I (carbohydrate antigens on red blood cells) |
5 |
| anti-ICOS (inducible T-cell co-stimulator, alias AILIM) |
6 |
| anti-IgD [mouse] allotype a |
2 |
| anti-IgE |
3 |
| anti-IgE [human] |
7 |
| anti-IgE receptor |
4 |
| anti-IgG [human] |
3 |
| anti-IgG rheumatoid factor |
3 |
| anti-InlB (internalins B) [Listeria monocytogenes] |
12 |
| anti-L-selectin |
16 |
| anti-L1CAM (neural cell adhesion molecule L1) [mouse] |
2 |
| anti-LDL receptor |
1 |
| anti-La (RNP, ribonucleoprotein) |
4 |
| anti-Lewis b [human] |
2 |
| anti-MN (tumor-associated-antigen) |
17 |
| anti-N(alpha)-(5'-phosphopyridoxyl)-L-lysine |
14 |
| anti-N-glycolyl GM3 (ganglioside GM3) |
2 |
| anti-NP |
13 |
| anti-NP (4-hydroxy-3-nitrophenyl (phenolate + phenolic form))acetyl |
2 |
| anti-NP (4-hydroxy-3-nitrophenyl (phenolate form)) acetyl |
43 |
| anti-NP (4-hydroxy-3-nitrophenylacetic acid) |
232 |
| anti-NP (4-hydroxy-3-nitrophenylacetic acid), anti-NIP (4-hydroxy-3-iodo-5-nitrophenylacetic acid) |
3 |
| anti-NP (4-hydroxy-3-nitrophenylacetic acid)-ficoll |
13 |
| anti-Neisseria meningitidis PorA protein P1.16 epitope |
4 |
| anti-Neisseria meningitidis PorA protein P1.7 epitope |
1 |
| anti-Neisseria meningitidis outer membrane protein P1.16 epitope |
2 |
| anti-P-selectin |
9 |
| anti-P7 Paragloboside |
1 |
| anti-PAF receptor |
3 |
| anti-PAH (polycyclic aromatic hydrocarbons) |
4 |
| anti-Pasteurella pneumotropica |
1 |
| anti-Plasmodium berghei Pbs21 antigen |
1 |
| anti-Plasmodium berghei ookinete protein Pbs21 |
2 |
| anti-Plasmodium circumsporozoite surface protein |
1 |
| anti-Plasmodium falciparum apical membrane antigen 1 (AMA1) |
2 |
| anti-Plasmodium falciparum merozoite surface protein-1 (MSP1) Block 2 region |
3 |
| anti-Plasmodium vivax |
1 |
| anti-Pseudomonas aeruginosa (B type) lipopolysaccharide (LPS) |
2 |
| anti-Pseudomonas aeruginosa (E type) lipopolysaccharide(LPS) |
2 |
| anti-Pseudomonas aeruginosa (F4 type) |
3 |
| anti-Pseudomonas aeruginosa (H1 type) |
4 |
| anti-Pseudomonas aeruginosa (I type) lipopolysaccharide(LPS) [human] |
2 |
| anti-Pseudomonas aeruginosa exotoxin |
6 |
| anti-Pseudomonas aeruginosa inner core oligosaccharide |
2 |
| anti-Pseudomonas aeruginosa lipid-A |
2 |
| anti-Pseudomonas aeruginosa lipopolysaccharide (LPS) A-band |
2 |
| anti-Pseudomonas aeruginosa lipopolysaccharide (LPS) O-antigen |
1 |
| anti-Pseudomonas aeruginosa lipopolysaccharide (LPS) O-antigen, serogroup 06ad |
2 |
| anti-Pseudomonas aeruginosa lipopolysaccharide (LPS) serotype IATS 05 O-antigen |
1 |
| anti-Pseudomonas aeruginosa lipopolysaccharide (LPS) serotype IATS 06 O-antigen |
2 |
| anti-Pseudomonas aeruginosa lipoprotein I (outer membrane protein I) |
2 |
| anti-Pseudomonas aeruginosa outer core oligosaccharide |
2 |
| anti-Pseudomonas lipopolysaccharide (LPS) |
2 |
| anti-RBC (red blood cells) |
2 |
| anti-RBC (red blood cells) [human] |
24 |
| anti-RBC (red blood cells) [mouse] |
3 |
| anti-RBC (red blood cells) [sheep] |
2 |
| anti-RNA |
4 |
| anti-RNA double-strand (ds) [rice dwarf virus (RDV)] |
10 |
| anti-RNA-bacteriophage fr |
2 |
| anti-Ralstonia solanacearum race 3 lipopolysaccharide (LPS) |
1 |
| anti-Rh(D) (blood group) |
122 |
| anti-SSEA-1 |
1 |
| anti-SSEA-1 fucosyl |
3 |
| anti-Schistosoma japonicum membrane protein |
2 |
| anti-Shigella dysenteriae type 1 polysaccharide |
2 |
| anti-Sia-1b (sialylated carbohydrates) (formerly anti-Gd) cold agglutinin |
1 |
| anti-Siglec-9 (dendritic cell (DC) membrane molecule) |
1 |
| anti-Sm |
96 |
| anti-Sm (ribonucleoprotein RNP) |
2 |
| anti-Sm (ribonucleoprotein RNP), anti-DNA double-stranded (ds) |
2 |
| anti-Sm (ribonucleoprotein RNP), anti-DNA double-stranded (ds), anti-glomerule (glomerular-binding, glomerulotropic) |
1 |
| anti-Sm (ribonucleoprotein RNP), anti-DNA single-stranded (ss) |
5 |
| anti-Streptococcus pneumonia (serotype 23F) (capsular polysaccharide) |
62 |
| anti-Streptococcus pneumonia (type 6B) (capsular polysaccharide) |
106 |
| anti-Syk (tyrosine kinase) |
2 |
| anti-T cell receptor beta chain |
3 |
| anti-T3 (triiodo-L-thyronine) (thyroid hormone) |
6 |
| anti-TNF alpha (tumor necrosis factor) |
14 |
| anti-TNF alpha (tumor necrosis factor) [human] |
25 |
| anti-TNP (2,4,6-trinitrophenyl) |
18 |
| anti-TNP (2,4,6-trinitrophenyl) H-2b class I-restricted |
20 |
| anti-TRAIL-R (TNF-related apoptosis-inducing ligand receptors ) |
2 |
| anti-TRAIL-R (TNF-related apoptosis-inducing ligand receptors) |
33 |
| anti-Tn (tumor-associated-antigen) |
4 |
| anti-Toxoplasma gondii |
2 |
| anti-Toxoplasma gondii P30 (major surface antigen) |
2 |
| anti-Toxoplasma gondii P66 antigen |
2 |
| anti-VSG (variant surface glycoprotein) |
7 |
| anti-Venezuelan equine encephalitis virus (VEE) |
1 |
| anti-Western equine encephalitis virus (WEE) |
1 |
| anti-abscisic acid |
1 |
| anti-acetylaminofluorene |
1 |
| anti-acetylcholine receptor |
42 |
| anti-acetyllysine |
17 |
| anti-acid phosphatase [Japanese radish] |
4 |
| anti-acidic isoferritin |
1 |
| anti-acidic isoferritin [Escherichia coli] |
1 |
| anti-activating transcription factor 1 |
2 |
| anti-adenocarcinoma |
2 |
| anti-adenocarcinoma [gastric human] (GA733-2) |
1 |
| anti-adseverin [human] |
1 |
| anti-aflatoxin |
2 |
| anti-aldolase |
16 |
| anti-aldolase [human] |
19 |
| anti-alkaline phosphatase [human placental] |
10 |
| anti-alkylphenol |
2 |
| anti-alkylphenol ethoxylate |
2 |
| anti-allergen Bet v1 (birch pollen allergen) |
9 |
| anti-allergen Der p1 (house dust mite antigen) |
3 |
| anti-allergen Poa p9 (Poa pratensis) peptide 26 |
5 |
| anti-alpha-2-antiplasmin |
60 |
| anti-alpha-fetoprotein |
2 |
| anti-alpha-fetoprotein [human] |
2 |
| anti-amiloride-binding protein |
2 |
| anti-angiotensin II |
2 |
| anti-anthrax toxin |
40 |
| anti-antigen BA46 [breast epithelial] |
2 |
| anti-apolipoprotein A [human] kringle domain |
2 |
| anti-apolipoprotein A [human] protease domain |
2 |
| anti-apolipoprotein A-I [human plasma] |
2 |
| anti-apolipoprotein B-100 [human plasma] |
4 |
| anti-apolipoprotein B-100 [human] |
2 |
| anti-apolipoprotein E [human] |
2 |
| anti-arsonate |
27 |
| anti-atrazine (pesticide) |
2 |
| anti-bacterial levan |
28 |
| anti-band 3 protein [human erythrocytes] |
2 |
| anti-bax inhibitor protein |
2 |
| anti-beet necrotic yellow vein virus (BNYVV) |
4 |
| anti-beta-2-glycoprotein I (beta2GPI) |
10 |
| anti-beta-amyloid 40 |
1 |
| anti-beta-amyloid [human peripheral blood] |
2 |
| anti-beta-amyloid peptide |
2 |
| anti-beta-galactosidase |
3 |
| anti-beta-lactamase |
1 |
| anti-biotin |
1 |
| anti-bisphenol A |
8 |
| anti-blood coagulation factor VIII (antihemophilic factor) |
17 |
| anti-blood coagulation factor VIII A3-C1 domains |
11 |
| anti-blood coagulation factor VIII C2 domain |
33 |
| anti-blood group antigen [human] |
1 |
| anti-botulinum neurotoxin type A (BoNT/A) |
40 |
| anti-c-erbB-2 (HUGO: ERBB2) |
54 |
| anti-c-myc (HUGO: MYC) peptide |
4 |
| anti-cancer |
8 |
| anti-cancer [colorectal] |
4 |
| anti-cancer [gastric human] |
2 |
| anti-cancer-associated antigen CA125 |
2 |
| anti-canine parvovirus capsid |
2 |
| anti-capsular glucuronoxylomannan (GXM) [Cryptococcus neoformans] |
19 |
| anti-carbohydrate antigen (Lewis Y) |
4 |
| anti-carbohydrate antigen (Lewis Y) (embryonic) |
2 |
| anti-carbohydrate antigen (Lewis Y) (tumor-associated) |
2 |
| anti-carboxypeptidase [bovine] |
1 |
| anti-carcinoembryonic antigen (CEA) (HUGO:CEACAM5) |
87 |
| anti-carcinoembryonic antigen (CEA71) |
1 |
| anti-carcinoma |
2 |
| anti-carcinoma [colorectal] |
8 |
| anti-carcinoma [human breast] |
2 |
| anti-carcinoma [human ovarian] |
1 |
| anti-carcinoma [human pulmonary] |
8 |
| anti-carcinoma [human] |
14 |
| anti-carcinoma [pulmonary] |
2 |
| anti-carcinoma surface antigen |
3 |
| anti-carcinoma surface antigen (GA733-2) |
1 |
| anti-cardiolipin |
69 |
| anti-cardiolipin, anti-beta-2-glycoprotein I (beta2GPI) |
4 |
| anti-cardiolipin/beta 2 glycoprotein I complex |
2 |
| anti-cathepsin L [human] |
1 |
| anti-chemokine receptor (CCR2) |
8 |
| anti-chloramphenicol (CAM) monoester (hydrolytic) |
12 |
| anti-chloramphenicol derivative |
2 |
| anti-chlorpyrifos-ethyl |
2 |
| anti-chondroitin sulphate proteoglycan (NG2) |
3 |
| anti-chorionic gonadotropin [human] (hcG) |
7 |
| anti-chorionic somatotropin [human] (HCS) |
1 |
| anti-chrysanthemate (insecticide) |
4 |
| anti-cocaine |
26 |
| anti-collagenase IV |
3 |
| anti-connective tissue growth factor |
19 |
| anti-core-streptavidin |
1 |
| anti-coronavirus |
1 |
| anti-cortisol |
4 |
| anti-crotoxin |
5 |
| anti-cruzipain |
1 |
| anti-cucumber mosaic virus (CMV) |
2 |
| anti-cucumber mosaic virus (CMV) (coat protein) |
2 |
| anti-cyclobutane type thymine dimer |
2 |
| anti-cyclosporine (Cs) |
2 |
| anti-cytidine, anti-guanosine |
4 |
| anti-cytochrome c |
2 |
| anti-cytochrome c [horse] |
4 |
| anti-cytochrome c [mammalian] |
21 |
| anti-cytochrome c [mouse] |
23 |
| anti-cytochrome c [pigeon] |
38 |
| anti-cytochrome c oxidase [mammalian] subunits VIac (nuclear encoded) |
1 |
| anti-cytokines [human] |
4 |
| anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) |
13 |
| anti-dansyl |
2 |
| anti-dendritic cells |
2 |
| anti-dengue virus |
6 |
| anti-deoxynivalenol (mycotoxin) |
2 |
| anti-desipramine (tricylic antidepressant) |
1 |
| anti-desmoglein 3 [human] |
1 |
| anti-desmosome |
2 |
| anti-dextran (alpha (1->6)) |
29 |
| anti-dextran B1355 |
43 |
| anti-dextran B512 |
1 |
| anti-digoxin |
144 |
| anti-dihydrolipoamide acetyltransferase (E2 subunit of pyruvate dehydrogenase complex) |
2 |
| anti-dihydrotestosterone |
2 |
| anti-disialoganglioside 2 |
1 |
| anti-diuron (a phenylurea herbicide) |
2 |
| anti-dyskerin |
2 |
| anti-eEF-1 alpha (translation Elongation Factor 1 alpha) |
1 |
| anti-eEF1A-1 (eukaryotic Elongation Factor 1A-1) |
2 |
| anti-epidermal growth factor receptor |
49 |
| anti-epithelial transmembrane glycoprotein-2 (EGP-2) [human] |
6 |
| anti-erbB-2 |
4 |
| anti-estradiol |
18 |
| anti-estrogen receptor [calf uterus] |
4 |
| anti-feline calici virus |
2 |
| anti-feline herpes virus-1 (FHV-1) |
2 |
| anti-ferritin [human] |
2 |
| anti-fibrin [human] |
1 |
| anti-fibroblast activation protein, alpha (FAP) |
18 |
| anti-fibroblast growth factor 8 (androgen-induced) (fgf-8) |
22 |
| anti-fibronectin ED-B domain (a marker of angiogenesis) |
24 |
| anti-fibronectin [human] |
1 |
| anti-flavocytochrome b2 |
1 |
| anti-flavocytochrome b2 [baker's yeast L-lactate dehydrogenase] |
1 |
| anti-fluorescein |
117 |
| anti-fluorescein (FITC) |
2 |
| anti-folate binding protein |
3 |
| anti-foot-and-mouth disease virus (FMDV) |
2 |
| anti-ganglioside GA1 (asialo GM1) |
2 |
| anti-ganglioside GD2 |
18 |
| anti-ganglioside GD3 |
69 |
| anti-ganglioside GM2 |
37 |
| anti-ganglioside GM2 [human type] |
2 |
| anti-gibberellin A24 |
2 |
| anti-gibberellin A4 (GA4) |
1 |
| anti-gingipain K protease (KGP) [Porphyromonas gingivalis] |
2 |
| anti-gliadin |
4 |
| anti-glioma [mouse] |
2 |
| anti-glioma surface antigen (cell cycle independent) |
4 |
| anti-glomerular basement membrane (GBM) |
8 |
| anti-glutathione |
4 |
| anti-glutathione S-transferase (GST) |
13 |
| anti-glycophorin A |
5 |
| anti-glycophorin A type M |
11 |
| anti-glycophorin A type M and type N [human] |
1 |
| anti-glycophorin A type N |
12 |
| anti-glycoprotein VI (GPVI) |
12 |
| anti-glycyrrhetic acid |
12 |
| anti-gp39 [human] |
12 |
| anti-granzyme B (GrB) |
4 |
| anti-growth hormone [human] (HGH) |
1 |
| anti-heat shock protein 70 (HSP70) [recombinant] [human] |
2 |
| anti-heat shock protein gp96 (grp94) |
7 |
| anti-hemagglutinin H3 [influenza virus] |
3 |
| anti-hemagglutinin [Porphyromonas gingivalis] |
1 |
| anti-hemagglutinin [influenza virus A/PR/8/34] |
1 |
| anti-hemagglutinin [influenza virus A] |
2 |
| anti-hemagglutinin [influenza virus] |
8 |
| anti-hepatitis A virus (HAV)capsid protein |
4 |
| anti-hepatitis B virus (HBV) X protein (HBx) |
3 |
| anti-hepatitis B virus (HBV) core protein |
9 |
| anti-hepatitis B virus (HBV) pre-S1 surface antigen |
2 |
| anti-hepatitis B virus (HBV) pre-S2 surface antigen |
2 |
| anti-hepatitis B virus (HBV) surface antigen (HBsAg) |
43 |
| anti-hepatitis B virus (HBV) surface antigen (HBsAg) (human) |
26 |
| anti-hepatitis C virus (HCV) |
7 |
| anti-hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) |
1 |
| anti-hepatitis C virus (HCV) core protein |
1 |
| anti-hepatitis C virus (HCV) envelope glycoprotein (E2) |
23 |
| anti-hepatitis C virus (HCV) non-structural 4A protein |
1 |
| anti-hepatitis C virus (HCV) non-structural 5A protein |
1 |
| anti-hepatitis C virus (HCV) non-structural protein 3 (NS3) |
1 |
| anti-hepatitis C virus (HCV) serine protease |
2 |
| anti-hepatitis E virus (HEV) ORF2 protein |
2 |
| anti-herpes simplex virus (HSV) |
8 |
| anti-herpes simplex virus (HSV) type 1 |
8 |
| anti-herpes simplex virus (HSV) type 1 and type 2 |
2 |
| anti-herpes simplex virus (HSV) type 1 glycoprotein B peptide (SSIEFARL)/H2-Kb class-I restricted |
7 |
| anti-herpes virus-1 (bovine) |
2 |
| anti-histamine |
2 |
| anti-histone |
32 |
| anti-histone H1 |
4 |
| anti-histone H2A |
2 |
| anti-histone H2A, H4 |
1 |
| anti-histone H2A/H2B |
2 |
| anti-histone H2B |
2 |
| anti-histone H3 |
2 |
| anti-histone H3A, H4 |
1 |
| anti-histone H4 |
2 |
| anti-histone, anti-nucleosome |
1 |
| anti-human cerebromicrovascular endothelial cells (HCEC) |
2 |
| anti-human cytomegalovirus (CMV) |
2 |
| anti-human cytomegalovirus (CMV) 65kD antigen |
2 |
| anti-human cytomegalovirus (CMV) glycoprotein B |
17 |
| anti-human cytomegalovirus (CMV) glycoprotein B antigenic domain 2 (AD-2) |
1 |
| anti-human cytomegalovirus (CMV) glycoprotein H |
4 |
| anti-human hepatitis A virus |
2 |
| anti-human milk fat globule |
26 |
| anti-i (carbohydrate antigens on red blood cells) |
2 |
| anti-idiotype |
235 |
| anti-idiotype (A48: levan-specific BALB/c myeloma protein ABPC48) |
8 |
| anti-idiotype (Ab3) (anti-Neisseria meningitidis polysaccharide C) |
1 |
| anti-idiotype (anti-sigma receptor) |
2 |
| anti-idiotype (anti-tumor effect) |
2 |
| anti-idiotype > cocaine |
1 |
| anti-idiotype > cyclosporine (Cs) |
2 |
| anti-idiotype HLA class II |
1 |
| anti-idiotype [human] |
2 |
| anti-idiotype, anti-cancer [human] |
18 |
| anti-idiotype, anti-epidermal growth factor receptor |
5 |
| anti-imidazolinone (herbicide) |
1 |
| anti-insulin |
17 |
| anti-insulin [beef] |
3 |
| anti-insulin [human] |
2 |
| anti-integrin IIIa (GPIIIa, glycoprotein IIIa) *L33 (P1A1, HPA-1a) [platelet] |
2 |
| anti-integrin IIb (GPIIb, glycoprotein IIb, integrin alphaIIb chain) [human platelet] |
4 |
| anti-integrin IIb/IIIa (GPIIb/IIIa, glycoprotein IIb/IIIa, integrin alphaIIb-beta3, fibrinogen receptor) |
10 |
| anti-integrin IIb/IIIa (GPIIb/IIIa, glycoprotein IIb/IIIa, integrin alphaIIb-beta3, fibrinogen receptor) [human platelet] |
34 |
| anti-integrin IIb/IIIa (GPIIb/IIIa, glycoprotein IIb/IIIa, integrin alphaIIb-beta3, fibrinogen receptor) [platelet] |
20 |
| anti-integrin Ia/IIa (GPIa/IIa, glycoprotein Ia/IIa, integrin alpha2-beta1, collagen receptor, VLA-2) [human platelet] |
2 |
| anti-integrin Ib (GPIb, glycoprotein Ib) [human platelet] |
2 |
| anti-integrin alpha4 chain |
4 |
| anti-integrin alpha4-beta7 |
46 |
| anti-intercellular adhesion molecule (ICAM) |
8 |
| anti-intercellular adhesion molecule-1 (ICAM-1) |
5 |
| anti-intercellular adhesion molecule-4 (ICAM-4) |
2 |
| anti-interferon gamma (IFNG) |
1 |
| anti-interferon gamma (IFNG) [human] |
6 |
| anti-interferon gamma receptor [human] (HUGO: IFNGR1) |
22 |
| anti-interleukin-1 (IL-1) |
1 |
| anti-interleukin-1 receptor (IL-1R) [human] |
4 |
| anti-interleukin-11 (IL-11) |
1 |
| anti-interleukin-18 precursor (IL-18) |
1 |
| anti-interleukin-18 receptor (IL-18R) [human] |
6 |
| anti-interleukin-2 receptor (IL-12R) [human] |
4 |
| anti-interleukin-2 receptor (IL-2R) |
4 |
| anti-interleukin-2 receptor (IL-2R) [human] |
8 |
| anti-interleukin-2 receptor (IL-2R) beta1 chain |
2 |
| anti-interleukin-2 receptor (IL-2R) p55 [human] |
2 |
| anti-interleukin-4 (IL-4) [human] |
18 |
| anti-interleukin-5 (IL-5) |
4 |
| anti-interleukin-5 receptor (IL-5R) [human] |
72 |
| anti-interleukin-6 (IL-6) [human] |
1 |
| anti-interleukin-6 (IL-6) [human] helix D region |
2 |
| anti-interleukin-6 receptor (IL-6R) [human] |
185 |
| anti-interleukin-8 (IL-8) |
95 |
| anti-interleukin-8 (IL-8) [human] |
24 |
| anti-interleukin-8 receptor (IL-8R) [human] |
10 |
| anti-keratin |
5 |
| anti-lactococcal bacteriophage p2 baseplate protein [Lactococcus lactis] |
7 |
| anti-laminin |
2 |
| anti-lipid A [bacterial] |
2 |
| anti-lipoprotein [human] |
6 |
| anti-liver-specific membrane lipoprotein [human] |
2 |
| anti-louping ill virus |
2 |
| anti-lysozyme |
4 |
| anti-lysozyme [hen egg white] |
6 |
| anti-lysozyme [hen egg white] [chicken] |
2 |
| anti-lysozyme [turkey egg white] |
8 |
| anti-macrophage migration inhibitory factor (MIF) |
12 |
| anti-malathion (pesticide) |
19 |
| anti-malonyl-CoA decarboxylase (MCD) [recombinant] [rat] |
4 |
| anti-medulloblastoma [human] |
1 |
| anti-medulloblastoma cell [human] |
2 |
| anti-melanocyte differentiation antigen TRP-2 [mouse] |
6 |
| anti-melanoma |
20 |
| anti-melanoma [human |
3 |
| anti-melanoma [human] |
5 |
| anti-melanoma [human] (anti-MAGE1 peptide/HLA-A1) |
2 |
| anti-melanoma [human] (anti-Pmel17/gp100 (HUGO: SILV) peptide/HLA-A2) |
1 |
| anti-mesothelin |
1 |
| anti-metal-EDTA (chelate) complex |
3 |
| anti-methamphetamine |
2 |
| anti-microcystin-LR [Microcystis aeruginosa] (cyanobacterial hepatotoxin) |
2 |
| anti-mitochondrial translocase (TOM70) [human] |
1 |
| anti-morphine |
30 |
| anti-mucin (MUC1) |
6 |
| anti-mucin (MUC1) [breast cancer associated] |
3 |
| anti-mucin (MUC1) core protein |
2 |
| anti-mucin [human breast] |
1 |
| anti-mucin type synthetic glycolipid |
2 |
| anti-multidrug resistance protein (MRP1) |
1 |
| anti-myelin |
2 |
| anti-myelin basic protein (MBP) [human] |
9 |
| anti-myelin basic protein (MBP) cross-reactive idiotope (CRI) |
2 |
| anti-myelin oligodendrocyte glycoprotein (MOG) |
14 |
| anti-myelin-associated glycoprotein (MAG) |
21 |
| anti-myelin-associated neurite growth inhibitors |
1 |
| anti-myeloperoxidase (MPO) |
29 |
| anti-myosin |
27 |
| anti-myosin, anti-N-acetyl-glucosamine (streptococcal polysaccharide) |
12 |
| anti-nerve growth factor (NGF) 30 (NGF30) |
2 |
| anti-neuraminidase |
2 |
| anti-neuroblastoma [human] |
2 |
| anti-neuropeptide substance P |
2 |
| anti-neurotensin G protein-coupled receptor NTS1 [human] |
2 |
| anti-neurotoxin AahI [Androctonus australis hector scorpion] (venom) |
3 |
| anti-nicotinic acetylcholine receptor (AChR) [human] |
8 |
| anti-nuclear |
44 |
| anti-nucleosome |
38 |
| anti-nucleosome, anti-DNA single-stranded (ss) |
1 |
| anti-nucleosome, anti-glomerule (glomerular-binding, glomerulotropic) |
2 |
| anti-nucleotide |
1 |
| anti-ovalbumin peptide (SIINFEKL)/H2-Kb class-I restricted |
11 |
| anti-ovomucoid |
6 |
| anti-oxidized LDL |
23 |
| anti-p-azobenzenearsonate |
9 |
| anti-p-azophenylarsonate |
14 |
| anti-p-azophenylarsonate-KLH (keyhole limpet hemocyanin) |
22 |
| anti-p-nitrophenyl phosphonate, esterolytic |
4 |
| anti-p21 RAS |
3 |
| anti-p53 (tumor-suppressor protein) |
2 |
| anti-paraquat (herbicide) |
3 |
| anti-parathion |
1 |
| anti-parathormone [human] related peptide |
38 |
| anti-parathyrin (PTHrP, parathyroid hormone-related protein) [human] |
2 |
| anti-parathyroid hormone |
38 |
| anti-peripherin |
2 |
| anti-phosphatidylcholine |
93 |
| anti-phosphatidylinositol-3,4,5-triphosphate |
2 |
| anti-phosphatidylserine |
2 |
| anti-phosphocholine |
25 |
| anti-phosphocholine [Proteus morganii] |
18 |
| anti-phosphocholine-KLH (keyhole limpet hemocyanin) |
74 |
| anti-phospholipid |
29 |
| anti-phospholipid [human platelet] |
2 |
| anti-phosphonate esters, catalytic, proteolytic |
1 |
| anti-phosphorylcholine |
16 |
| anti-phosphorylcholine (low-affinity) |
5 |
| anti-phthalate |
2 |
| anti-picloram |
2 |
| anti-plasminogen activator inhibitor type-1 (PAI-1) |
22 |
| anti-plum pox virus (PPV) RNA replicase NIb |
1 |
| anti-pneumococcal |
14 |
| anti-pneumococcal [human] |
8 |
| anti-pneumococcal capsular polysaccharide |
28 |
| anti-pneumococcal capsular polysaccharide serotype 6B |
4 |
| anti-pneumococcal, anti-DNA double-stranded (ds) |
12 |
| anti-pneumolysin |
4 |
| anti-poliovirus type 1 |
2 |
| anti-poly(A)/poly(U) |
3 |
| anti-poly(A)/poly(dT) |
2 |
| anti-poly(dC) |
18 |
| anti-polycation |
18 |
| anti-porphyrin |
6 |
| anti-potato cyst nematode |
2 |
| anti-potato virus V coat protein |
1 |
| anti-potato virus Y (PVY) nuclear inclusion (NIa) |
5 |
| anti-procollagenase [human] |
23 |
| anti-prostate |
2 |
| anti-proteolipid protein (PLP) |
4 |
| anti-pseudouridine |
4 |
| anti-rabies virus |
8 |
| anti-respiratory syncytial virus (RSV) |
48 |
| anti-rhinovirus HRV2 [human] |
2 |
| anti-ribosomal P (phospho-) protein (systemic lupus erythematosus) (SLE) |
4 |
| anti-ribosomal P (phospho-) protein [eukaryote] |
1 |
| anti-rice stripe virus P20 protein |
1 |
| anti-rotavirus VP7 |
195 |
| anti-seminoprotein [human] |
1 |
| anti-serum albumin [bovine] |
3 |
| anti-serum albumin [human] |
1 |
| anti-severe acute respiratory syndrome coronavirus (SARS) |
17 |
| anti-shiga toxin 1 (Stx1) |
2 |
| anti-sialoprotein protein Fv (pFv) 175 kDa [human] gut-associated |
6 |
| anti-signaling lymphocytic activation molecule (SLAM) |
1 |
| anti-simetryn (herbicide) |
2 |
| anti-sm |
9 |
| anti-solamargine |
1 |
| anti-sperm [human] (immobilising) |
1 |
| anti-sperm agglutination antigen-1 (SAGA-1) (sperm glycoform of CD25) [human] carbohydrate epitope |
1 |
| anti-staphylococcal nuclease |
2 |
| anti-steroids |
18 |
| anti-streptococcal polyglycerol phosphate |
1 |
| anti-streptococcal, anti-myosin |
9 |
| anti-tenascin-C (TN-C) [human] |
1 |
| anti-testosterone |
7 |
| anti-testosterone [bovine] |
1 |
| anti-tetanus |
6 |
| anti-tetanus toxoid (TeTox) |
7 |
| anti-thrombospondin |
12 |
| anti-thymocyte [mouse] |
8 |
| anti-thyroglobulin |
5 |
| anti-thyroglobulin [bovine] |
3 |
| anti-thyroglobulin [human] |
2 |
| anti-thyroid [human] (stimulating autoantibody) |
4 |
| anti-thyroid hormone |
2 |
| anti-thyroid peroxidase (TPO) |
272 |
| anti-thyroid peroxidase (TPO) (degraded) |
109 |
| anti-thyroid stimulating hormone (TSH) [human] |
2 |
| anti-thyrotropin receptor [human] |
9 |
| anti-tissue factor [human] |
4 |
| anti-tobacco mosaic virus (TMV) |
2 |
| anti-transferrin [human] |
2 |
| anti-transferrin receptor [human] |
4 |
| anti-transferrin receptor [rat] |
1 |
| anti-transforming growth factor beta II receptor (TGF-beta-II receptor) |
18 |
| anti-transition state analogue |
10 |
| anti-transition state analogue (nitrophenyl phosphonate) |
2 |
| anti-transmembrane antigen [breast human] |
2 |
| anti-transmissible gastroenteritis coronavirus (TGEV) |
1 |
| anti-triazine (herbicide) |
2 |
| anti-trypsin |
1 |
| anti-tryptophan synthase beta-subunit [Escherichia coli] |
2 |
| anti-tumor |
14 |
| anti-tumor associated antigen |
2 |
| anti-tumor surface antigen |
2 |
| anti-tumor surface antigen p185 |
4 |
| anti-tumor-associated glycoprotein-72 (TAG-72) |
1 |
| anti-tumor-associated glycoprotein-72 (TAG-72) [human] |
4 |
| anti-type II collagen (CII) |
2 |
| anti-urokinase plasminogen activator receptor (uPAR) [human] |
2 |
| anti-urokinase receptor |
2 |
| anti-varicella-zoster virus (VZV) |
2 |
| anti-vascular cell adhesion molecule (VCAM) [porcine] |
4 |
| anti-vascular endothelial growth factor (VEGF) |
1 |
| anti-vascular endothelial growth factor (VEGF) [human] |
9 |
| anti-verotoxin II |
4 |
| anti-vesicular stomatitis virus (VSV) |
13 |
| anti-viral haemorrhagic septicaemia virus (vhsv) |
7 |
| anti-von Willebrand Factor (vWF) |
8 |
| anti-white pine blister rust |
1 |
| anti-yellow grouper nervous necrosis virus (YGNNV) coat protein |
2 |
| anti-zearalenone (mycotoxin) |
2 |